{
    "id": "c38c5db5-ebfb-5d56-d407-27f67a749aee",
    "contraindications": {
        "text": "note : contains benzyl alcohol ( ) parenteral products inspected visually particulate matter discoloration prior whenever solution container permit . glycopyrrolate injection may administered intramuscularly , intravenously , without dilution , following .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "glycopyrrolate injection , usp , 0.2 mg/ml , available : 1 ml single dose vials ( ndc 16714-536-01 ) packaged 25s ( ndc 16714-536-25 ) 2 ml single dose vials ( ndc 16714-620-01 ) packaged 25s ( ndc 16714-620-25 ) store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . report suspected , contact northstar rx llc 1-800-206-7821 , fda 1-800\u2011fda\u20111088 www.fda.gov/medwatch . registered trademarks document property respective owners . manufactured : manufactured : indoco remedies limited l-32 , 33 , 34 , verna industrial area , verna , goa-403722 , india northstar rx llcmemphis , tn 38141 revised : april 2022",
    "adverseReactions": "known hypersensitivity glycopyrrolate inactive ingredients . addition , management peptic ulcer patients , longer duration therapy , glycopyrrolate injection may contraindicated patients following concurrent conditions : glaucoma ; obstructive uropathy ( example , bladder neck obstruction due prostatic hypertrophy ) ; obstructive disease gastrointestinal tract ( achalasia , pyloroduodenal stenosis , etc . ) ; paralytic ileus , intestinal atony elderly debilitated patient ; unstable cardiovascular status acute hemorrhage ; severe ulcerative colitis ; toxic megacolon complicating ulcerative colitis ; myasthenia gravis .",
    "ingredients": [
        {
            "name": "GLYCOPYRROLATE",
            "code": "V92SO9WP2I",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00986"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        }
    ],
    "organization": "NORTHSTAR RX LLC",
    "name": "Glycopyrrolate",
    "effectiveTime": "20250521",
    "contraindications_original": "NOTE: CONTAINS BENZYL ALCOHOL (see \n                        PRECAUTIONS\n                     ) \n                  Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.\n                  Glycopyrrolate injection may be administered intramuscularly, or intravenously, without dilution, in the following indications.",
    "warningsAndPrecautions_original": "Glycopyrrolate injection, USP, 0.2 mg/mL, is available in:\n                  \n                  1 mL single dose vials (NDC 16714-536-01) packaged in 25s (NDC 16714-536-25) 2 mL single dose vials (NDC 16714-620-01) packaged in 25s (NDC 16714-620-25) \n                  \n                  \n                     Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted from 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [See USP Controlled Room Temperature].\n                  \n                  To report SUSPECTED ADVERSE REACTIONS, contact Northstar Rx LLC at 1-800-206-7821, or the FDA at 1-800\u2011FDA\u20111088 or www.fda.gov/medwatch.\n                  All registered trademarks in this document are the property of their respective owners.\n                  \n                  \n                     \n                        \n                           Manufactured by:\n                           Manufactured for:\n                        \n                        \n                           Indoco Remedies Limited L-32, 33, 34, Verna Industrial Area, Verna, Goa-403722, India\n                           Northstar Rx LLCMemphis, TN 38141\n                              \n                              \n                           \n                        \n                     \n                  \n                  Revised: April 2022",
    "adverseReactions_original": "Known hypersensitivity to glycopyrrolate or any of its inactive ingredients.\n                     In addition, in the management of peptic ulcer patients, because of the longer duration of therapy, glycopyrrolate injection may be contraindicated in patients with the following concurrent conditions: glaucoma; obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); paralytic ileus, intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis.",
    "drug": [
        {
            "name": "Glycopyrrolate",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00986"
        }
    ]
}